1 December 2023 in Journal of Applied Physiology
LCLauren M. Colenso-Semple
+6
Hormonal changes around ovulation divide the menstrual cycle (MC) into the follicular and luteal phases. In addition, oral contraceptives (OCs) have active (higher hormone) and placebo phases. Although there are some MC-based effects on various physiological outcomes, we found these differences relatively subtle and difficult to attribute to specific hormones, as estrogen and progesterone fluctuate rather than operating in a complete on/off pattern as observed in cellular or preclinical models often used to substantiate human data. A broad review reveals that the differences between the follicular and luteal phases and between OC active and placebo phases are not associated with marked differences in exercise performance and appear unlikely to influence muscular hypertrophy in response to resistance exercise training. A systematic review and meta-analysis of substrate oxidation between MC phases revealed no difference between phases in the relative carbohydrate and fat oxidation at rest and during acute aerobic exercise. Vascular differences between MC phases are also relatively small or nonexistent. Although OCs can vary in composition and androgenicity, we acknowledge that much more work remains to be done in this area; however, based on what little evidence is currently available, we do not find compelling support for the notion that OC use significantly influences exercise performance, substrate oxidation, or hypertrophy. It is important to note that the study of females requires better methodological control in many areas. Previous studies lacking such rigor have contributed to premature or incorrect conclusions regarding the effects of the MC and systemic hormones on outcomes. While we acknowledge that the evidence in certain research areas is limited, the consensus view is that the impact of the MC and OC use on various aspects of physiology is small or nonexistent.
10 January 2024 in The FASEB Journal
1 July 2020 in Medicine & Science in Sports & Exercise
1 October 2024 in Medicine & Science in Sports & Exercise
26 April 2026 in Physiological Reports
Females exhibit distinct responses to exercise‐induced muscle damage, possibly due to circulating hormone profiles. Despite the widespread use of oral contraceptives (OC) among females, the muscle damage and repair response during synthetic hormone use remains unknown. This study investigated how ethinyl estradiol (EE) and synthetic progestins [representing the different OC generations: medroxyprogesterone acetate (MPA), OC1; levonorgestrel (LNG), OC2; desogestrel (DSG), OC3; and drospirenone (DRP), OC4] influence C2C12 myoblast behavior. We examined proliferation, differentiation, and migration at baseline and following electrical pulse stimulation (EPS). While MPA and LNG alone increased myoblast proliferation (~19%; p < 0.05), their combination with EE (creating OC1 and OC2, respectively) reduced proliferation (15%–17%; p < 0.05) versus the vehicle control (VEH). All OC formulations significantly impaired migration (46%–61%; p < 0.001) without affecting differentiation. Post‐EPS, only OC1 and OC2 conditions showed elevated creatine kinase alongside upregulated early myogenic proteins and modulation of hormone receptors. These results indicate that synthetic sex hormones in OCs can significantly alter myoblast responses to damaging stimuli in a generation‐specific manner. OC use may influence muscle repair processes differently than natural hormonal profiles, highlighting the need for further investigation into how contraceptive formulations affect exercise recovery in women.
1 May 2026 in American Journal of Physiology-Cell Physiology
17β-Estradiol (E2) and progesterone (P4) may differentially regulate myoblast function, with high concentrations suppressing proliferation. Notably, E2 enhances muscle repair after electrical stimulation, but P4 may influence this response when combined with E2 to simulate menstrual cycle phases. The discovery that ERα increases across all hormone treatments suggests a key regulatory role in muscle contractile responses. These findings provide novel insights into how menstrual cycle hormones may influence exercise recovery and muscle adaptation.